Insertion of the 5′ Part of BCR within the ABL Gene at 9q34 in a Philadelphia-negative Chronic Myeloid Leukemia

• Published in: Cancer genetics and cytogenetics 1999-10, Vol.114 (1), p.17-21
• Main Authors: Vieira, Luı́s, Alves, Ana C, Marques, Bárbara, Reis, Isabel, Jorge, Graça, Ambrósio, Ana P, de Sousa, Aida B, Boavida, Maria Guida
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Chromosomes, Human, Pair 9; Female; Fusion Proteins, bcr-abl - genetics; Hematologic and hematopoietic diseases; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative - genetics; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; Medical sciences; Middle Aged; Mutagenesis, Insertional; Mutation; Philadelphia Chromosome
• ISSN: 0165-4608; 1873-4456
• DOI: 10.1016/S0165-4608(99)00036-9

We report a chronic myeloid leukemia patient without evidence of a Philadelphia (Ph) chromosome in whom RT-PCR analysis performed in blast crisis demonstrated the existence of both common b3a2 and b2a2 BCR/ ABL fusion transcripts. In situ hybridization studies with BCR- and ABL-specific probes showed location of the BCR/ ABL fusion gene on chromosome 9, band q34, instead of at chromosome 22q11, and that it resulted from an insertion of the 5′ side of BCR within the ABL gene on chromosome 9. The vast majority of cells showed a BCR/ ABL fusion gene on both chromosomes 9, which is equivalent to a double Ph chromosome, thus reinforcing the notion that the critical event in CML is the formation of a functional BCR/ABL fusion gene.